A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

Clinical trial NCT06391177 · COMPLETED

Trial details

NCT number: NCT06391177
Sponsor: Phathom Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Erosive Esophagitis Heartburn Symptomatic Nonerosive Gasroesophageal Reflux Disease Helicobacter Pylori Infection

Start date: 2024-05-07
Primary completion: 2024-09-13
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.